Skip to main content

Advertisement

Table 4 Summary of the data sets and the classification results based on 50 random sampling

From: A simpler method of preprocessing MALDI-TOF MS data for differential biomarker analysis: stem cell and melanoma cancer studies

Data set Class Sample type Sample size Total peaks Training set (MCCV) Blind data set
      Train Test Validation  
Melanoma S2 v. S3 Serum 99 2560 41 14 14 30
Classification (%)      93.21 97.38 90.62 90.93
Cord blood High v. Low Plasma 158 2647 67 22 22 47
Classification (%)      96.45 96.73 91.18 92.34